DRKS00012928RecruitingNot Applicable
Is The Occurrence of IgA-Nephropathy modulated by Gene Mutations of Phase 1 and 2 Detoxification Enzymes? - GP&IGA
Förderverein Nephrologie e.V.0 sites200 target enrollmentStarted: September 29, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to 90 Years (—)
- Sex
- All
Inclusion Criteria
- •Histologic proven IgA nephropathy in Caucasians of either sex
- •For the controls: chronic kidney disease patients without glomerulonephritis in Caucasians of either sex
- •Further controls: published SNP- frequencies of phase I and II gene (rate of polymorphisms in the general population)
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Not Applicable
Effect of Immunosuppression in IgA nephropathyKCT0003039Yonsei University Health System, Severance Hospital172
Completed
Phase 1
Influence of IgA Nephropathy ? Prescription on Serum Gd-IgA1 and BAFF level for Patients with IgA NephropathyITMCTR2200005824HuQianqian
Recruiting
Phase 4
Dapagliflozin treatment in IgA nephropathy patientsIgA nephropathyJPRN-jRCT1031220369Tomohito Gohda150
Completed
Not Applicable
Impact of immunosuppressive therapy in IgA nephropathyN03.3DRKS00025167niversitätsklinikum Freiburg131
Not yet recruiting
Not Applicable
Detection of risk factors for IgA nephritisIgA nephritisJPRN-UMIN000038058Department of Organ transplantation and General Surgery Kyoto Prefectural University of Medicine Kajii-cho 465, Kamigyo-ku, Kyoto, Japan100